News
HEALTHCARE | Staff Reporter, Hong Kong
view(s)

ITC earmarks $2m per R&D project to curb COVID-19

It will fund R&D trials related to detection, diagnosis or surveillance of the virus.

The Innovation and Technology Commission (ITC) is earmarking up to $2m each project in a special call for the research and development (R&D) of products and technologies designed to prevent and control the COVID-19 pandemic, according to a press release.

This aims to fund trials of R&D related to detection, diagnosis or surveillance of the virus, or reduction of the risks of infection and its spread. The outcomes will have to be immediately ready for trials by government departments or the relevant public organisations.

ITC may consider a higher ceiling for individual projects if necessary. The maximum duration of a project is 12 months, and priority will be given to projects that can be completed within a shorter time frame.

Applications are open until 10 April. The target funding recipients are local R&D centres, universities and public research institutes, as well as all technology companies conducting R&D activities in Hong Kong.

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.